2017 Q3 Form 10-Q Financial Statement

#000094480917000008 Filed on August 08, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2017 Q2 2016 Q2
Revenue $246.0M $292.6M $332.3M
YoY Change -8.65% -11.95% 683.24%
Cost Of Revenue $135.2M $143.9M $141.0M
YoY Change -2.42% 2.08% 876.66%
Gross Profit $110.8M $148.7M $191.4M
YoY Change -15.25% -22.29% 583.52%
Gross Profit Margin 45.05% 50.82% 57.58%
Selling, General & Admin $103.2M $105.6M $117.5M
YoY Change -17.36% -10.15% 461.26%
% of Gross Profit 93.09% 71.0% 61.41%
Research & Development $32.51M $33.13M $31.35M
YoY Change 33.1% 5.68% 6.01%
% of Gross Profit 29.33% 22.28% 16.38%
Depreciation & Amortization $25.39M $25.55M $24.58M
YoY Change -1.7% 3.95% 492.0%
% of Gross Profit 22.91% 17.18% 12.85%
Operating Expenses $293.8M $318.4M $308.7M
YoY Change -2.14% 3.16% 355.02%
Operating Profit -$47.77M -$25.83M $28.27M
YoY Change 102.2% -191.39% -211.24%
Interest Expense -$9.100M $4.100M -$800.0K
YoY Change 19.74% -612.5% -95.43%
% of Operating Profit -2.83%
Other Income/Expense, Net -$8.544M $3.583M $5.123M
YoY Change -18.84% -30.06% -130.54%
Pretax Income -$56.31M -$22.25M $33.39M
YoY Change 64.88% -166.63% -179.15%
Income Tax -$24.41M -$10.96M $15.87M
% Of Pretax Income 47.52%
Net Earnings -$35.92M -$16.92M $10.91M
YoY Change 61.5% -255.05% -125.23%
Net Earnings / Revenue -14.6% -5.78% 3.28%
Basic Earnings Per Share -$0.06 -$0.03 $0.02
Diluted Earnings Per Share -$0.06 -$0.04 $0.01
COMMON SHARES
Basic Shares Outstanding 559.4M shares 559.3M shares 547.6M shares
Diluted Shares Outstanding 564.2M shares 557.0M shares

Balance Sheet

Concept 2017 Q3 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.4M $130.5M $171.6M
YoY Change -30.57% -23.95% -22.42%
Cash & Equivalents $100.4M $130.5M $156.0M
Short-Term Investments $15.60M
Other Short-Term Assets $3.880M $3.287M $776.0K
YoY Change 343.94% 323.58% -77.1%
Inventory $46.95M $48.29M $42.05M
Prepaid Expenses
Receivables $233.9M $251.7M $213.4M
Other Receivables $29.90M $28.00M $66.00M
Total Short-Term Assets $430.6M $472.5M $505.6M
YoY Change -14.24% -6.54% 81.64%
LONG-TERM ASSETS
Property, Plant & Equipment $142.4M $133.4M $128.3M
YoY Change 13.51% 3.96% 448.06%
Goodwill $715.6M $712.1M $691.1M
YoY Change 2.15% 3.04% 138.62%
Intangibles
YoY Change
Long-Term Investments $30.20M $31.00M $33.40M
YoY Change -17.71% -7.19% 190.43%
Other Assets $38.30M $39.16M $4.385M
YoY Change 789.64% 793.09% -27.07%
Total Long-Term Assets $2.291B $2.296B $2.268B
YoY Change -0.28% 1.22% 81.89%
TOTAL ASSETS
Total Short-Term Assets $430.6M $472.5M $505.6M
Total Long-Term Assets $2.291B $2.296B $2.268B
Total Assets $2.722B $2.769B $2.774B
YoY Change -2.79% -0.19% 81.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $66.54M $62.15M $61.06M
YoY Change 13.65% 1.79% 280.71%
Accrued Expenses $176.3M $206.4M $209.8M
YoY Change -5.25% -1.64% 40.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $16.11M $14.50M $10.33M
YoY Change 62.9% 40.37% -29.26%
Total Short-Term Liabilities $258.9M $283.1M $281.2M
YoY Change 1.74% 0.65% 55.83%
LONG-TERM LIABILITIES
Long-Term Debt $1.162M $1.560M $1.807M
YoY Change -48.19% -13.67% -15.88%
Other Long-Term Liabilities $226.6M $201.8M $224.3M
YoY Change 11.04% -10.02% -45.13%
Total Long-Term Liabilities $374.0M $378.8M $477.1M
YoY Change -15.02% -20.61% -7.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $258.9M $283.1M $281.2M
Total Long-Term Liabilities $374.0M $378.8M $477.1M
Total Liabilities $633.0M $661.9M $758.4M
YoY Change -8.88% -12.73% 8.57%
SHAREHOLDERS EQUITY
Retained Earnings -$792.4M -$745.9M -$701.3M
YoY Change 10.62% 6.36% -15.98%
Common Stock $5.600M $5.600M $5.483M
YoY Change 0.34% 2.13% 18.02%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.791M $1.791M $1.911M
YoY Change -6.28% -6.28% -47.57%
Treasury Stock Shares 549.9K shares 549.9K shares 586.8K shares
Shareholders Equity $2.089B $2.107B $2.016B
YoY Change
Total Liabilities & Shareholders Equity $2.722B $2.769B $2.774B
YoY Change -2.79% -0.19% 81.84%

Cashflow Statement

Concept 2017 Q3 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$35.92M -$16.92M $10.91M
YoY Change 61.5% -255.05% -125.23%
Depreciation, Depletion And Amortization $25.39M $25.55M $24.58M
YoY Change -1.7% 3.95% 492.0%
Cash From Operating Activities -$37.60M -$22.70M $42.80M
YoY Change 17.87% -153.04% -225.51%
INVESTING ACTIVITIES
Capital Expenditures -$15.30M -$7.300M -$3.100M
YoY Change 68.13% 135.48% 210.0%
Acquisitions
YoY Change
Other Investing Activities -$1.100M -$2.700M -$20.50M
YoY Change -103.85% -86.83% -78.87%
Cash From Investing Activities -$16.30M -$10.00M -$23.60M
YoY Change -183.59% -57.63% -75.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 22.90M 31.70M -38.00M
YoY Change 2444.44% -183.42% -908.51%
NET CHANGE
Cash From Operating Activities -37.60M -22.70M 42.80M
Cash From Investing Activities -16.30M -10.00M -23.60M
Cash From Financing Activities 22.90M 31.70M -38.00M
Net Change In Cash -31.00M -1.000M -18.80M
YoY Change 169.57% -94.68% -85.25%
FREE CASH FLOW
Cash From Operating Activities -$37.60M -$22.70M $42.80M
Capital Expenditures -$15.30M -$7.300M -$3.100M
Free Cash Flow -$22.30M -$15.40M $45.90M
YoY Change -2.19% -133.55% -238.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000944809
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
559404941 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Opko Health, Inc.
CY2016Q4 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
5935000 USD
CY2017Q2 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
9176000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent
3000000 USD
CY2016Q4 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
4865000 USD
CY2017Q2 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
4966000 USD
CY2016Q4 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
2100000000 USD
CY2017Q2 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
2100000000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
325000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
1546000 USD
CY2016Q4 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
10 institution
CY2017Q2 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
11 institution
CY2017Q2 opk Equity Method Investment Excluding Variable Interest Entity
EquityMethodInvestmentExcludingVariableInterestEntity
24353000 USD
CY2017Q2 opk Equity Method Investment Variable Interest Entity
EquityMethodInvestmentVariableInterestEntity
212000 USD
CY2016Q2 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
17521000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
7887000 USD
CY2017Q2 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-11900000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-40765000 USD
opk Increase Decreasein Foreign Currency Measurement
IncreaseDecreaseinForeignCurrencyMeasurement
-405000 USD
opk Increase Decreasein Foreign Currency Measurement
IncreaseDecreaseinForeignCurrencyMeasurement
230000 USD
CY2016Q2 opk Interest Expense Nonoperating
InterestExpenseNonoperating
2217000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
4004000 USD
CY2017Q2 opk Interest Expense Nonoperating
InterestExpenseNonoperating
1502000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
2931000 USD
CY2016Q2 opk Interest Income Nonoperating
InterestIncomeNonoperating
135000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
178000 USD
CY2017Q2 opk Interest Income Nonoperating
InterestIncomeNonoperating
136000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
385000 USD
opk Numberof Sales Employees
NumberofSalesEmployees
400 employee
CY2017Q2 opk Percentage Of Increase Decrease In Future Sales
PercentageOfIncreaseDecreaseInFutureSales
-0.1
CY2016Q2 opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
68281000 USD
opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
86898000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
877000 USD
CY2017Q2 opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
28576000 USD
opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
47154000 USD
CY2016Q2 opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
121156 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
125380 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
125380 shares
CY2017Q2 opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
187875 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
272857 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
272857 shares
CY2016Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
439238 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
2238537 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
2238537 shares
CY2017Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
539500 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
1646372 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
1646372 shares
CY2016Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
318082 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
2113157 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
2113157 shares
CY2017Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
351625 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
1373515 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
1373515 shares
CY2017Q2 opk Stock Optionand Warrant Investments
StockOptionandWarrantInvestments
2608000 USD
CY2016Q4 opk Taxes Recoverable Current
TaxesRecoverableCurrent
16187000 USD
CY2017Q2 opk Taxes Recoverable Current
TaxesRecoverableCurrent
15416000 USD
CY2016Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
13021000 USD
CY2017Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
12516000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
53360000 USD
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
62153000 USD
CY2016Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
256552000 USD
CY2017Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
306967000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
220284000 USD
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
251747000 USD
CY2016Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
43792000 USD
CY2017Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
48631000 USD
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4430000 USD
CY2017Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5879000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
197955000 USD
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
206403000 USD
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4035000 USD
CY2017Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4067000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27009000 USD
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14070000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2845096000 USD
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2863025000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
36268000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
36300000 USD
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
55220000 USD
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
55200000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
74000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
112000 USD
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15778000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29221000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29200000 USD
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17953000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35881000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35900000 USD
CY2016Q4 us-gaap Assets
Assets
2766619000 USD
CY2017Q2 us-gaap Assets
Assets
2768694000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
483601000 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
472516000 USD
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
4528000 USD
CY2017Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3785000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1313000 USD
CY2017Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1152000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
194000 USD
CY2017Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
182000 USD
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
3409000 USD
CY2017Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
2815000 USD
CY2017Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
3785000 USD
CY2016Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
10758000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12511000 USD
CY2017Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4366000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
6738000 USD
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
45100000 USD
CY2017Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
51500000 USD
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
259000 USD
CY2017Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5081000 USD
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
44817000 USD
CY2017Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
46434000 USD
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3025000 USD
CY2017Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3464000 USD
CY2016Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
7216000 USD
CY2017Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
8488000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
193598000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156015000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
168733000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130530000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-37583000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-38203000 USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
558576051 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
559955118 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
5586000 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
5600000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9212000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2660000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6645000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-35584000 USD
CY2016Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
43701000 USD
CY2017Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
34758000 USD
CY2017Q2 us-gaap Cost Method Investments
CostMethodInvestments
3537000 USD
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
12468000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
22407000 USD
CY2017Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
13505000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
28334000 USD
CY2016Q2 us-gaap Cost Of Services
CostOfServices
140971000 USD
us-gaap Cost Of Services
CostOfServices
278568000 USD
CY2017Q2 us-gaap Cost Of Services
CostOfServices
143901000 USD
us-gaap Cost Of Services
CostOfServices
283867000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8999000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23039000 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
165331000 USD
CY2017Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
142212000 USD
CY2016Q4 us-gaap Deferred Revenue
DeferredRevenue
162400000 USD
CY2017Q2 us-gaap Deferred Revenue
DeferredRevenue
128500000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
73434000 USD
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
74954000 USD
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
89016000 USD
CY2017Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
53537000 USD
us-gaap Depreciation
Depreciation
17600000 USD
us-gaap Depreciation
Depreciation
15400000 USD
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24580000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46780000 USD
CY2017Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25551000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
51281000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
423000 USD
CY2016Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-4872000 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-4734000 USD
CY2017Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-5069000 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-10000000 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-10014000 USD
CY2017Q2 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
39600000 USD
CY2017Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
435700000 USD
CY2017Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
194000000 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-57500000 USD
CY2017Q2 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
26421000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
123207000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
160138000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
763976000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
731134000 USD
CY2016Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1235000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-188000 USD
CY2017Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
5482000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
9519000 USD
CY2016Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1988000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-4333000 USD
CY2017Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-5628000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-7758000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
2494000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
2473000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
704603000 USD
CY2017Q2 us-gaap Goodwill
Goodwill
712075000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
7472000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
33389000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3249000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-22860000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-58669000 USD
CY2016Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1988000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4333000 USD
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5628000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7758000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15868000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4638000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10960000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17904000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7172000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4321000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13205000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9439000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18388000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30865000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
33452000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3837000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-35938000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-34018000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1763000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
443000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-732000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
254000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14309000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3692000 USD
CY2016Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
661000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1267000 shares
CY2017Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
4556000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
4556000 shares
CY2017Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
4816000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
4725000 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4264000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4222000 shares
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2016Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
644713000 USD
CY2017Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
645957000 USD
CY2016Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
604000 USD
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
1196000 USD
CY2017Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
652000 USD
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
1291000 USD
us-gaap Interest Paid
InterestPaid
900000 USD
us-gaap Interest Paid
InterestPaid
748000 USD
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
16143000 USD
CY2017Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
21822000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
47228000 USD
CY2017Q2 us-gaap Inventory Net
InventoryNet
48293000 USD
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4686000 USD
CY2017Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
6352000 USD
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
945000 USD
CY2017Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5977000 USD
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3896000 USD
CY2017Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4983000 USD
us-gaap Inventory Write Down
InventoryWriteDown
200000 USD
us-gaap Inventory Write Down
InventoryWriteDown
4800000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
674811000 USD
CY2017Q2 us-gaap Liabilities
Liabilities
661865000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2766619000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2768694000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
263296000 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
283052000 USD
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
411515000 USD
CY2017Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
378813000 USD
CY2016Q4 us-gaap Line Of Credit
LineOfCredit
47321000 USD
CY2017Q2 us-gaap Line Of Credit
LineOfCredit
80739000 USD
CY2017Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
191078000 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11981000 USD
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
14496000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
717000 USD
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1560000 USD
CY2016Q4 us-gaap Long Term Investments
LongTermInvestments
41139000 USD
CY2017Q2 us-gaap Long Term Investments
LongTermInvestments
34495000 USD
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
38809000 USD
CY2017Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
69700000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37933000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33915000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33709000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16412000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33636000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-56583000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15533000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3554000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17528000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-48523000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
11265000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21945000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-57246000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5123000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2501000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3583000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9482000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
328834000 USD
us-gaap Operating Expenses
OperatingExpenses
647390000 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
340656000 USD
us-gaap Operating Expenses
OperatingExpenses
678458000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
28266000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
748000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-26443000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-68151000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
58180000 USD
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
50185000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7508000 USD
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
3287000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5756000 USD
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39162000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4432000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2510000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10495000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13088000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-594000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-594000 USD
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1889000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3404000 USD
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-206000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-743000 USD
CY2016Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
23448000 USD
CY2017Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
21113000 USD
CY2016Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
21908000 USD
CY2017Q2 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
22124000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
202483000 USD
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
201843000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5970000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6515000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-533000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2509000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
1408000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
1294000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5921000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15630000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
12866000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
16805000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47356000 USD
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
41946000 USD
CY2016Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3688000 USD
CY2017Q2 us-gaap Prepaid Insurance
PrepaidInsurance
2162000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1912000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1916000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
9496000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
45524000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
708000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3398000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
15533000 USD
us-gaap Profit Loss
ProfitLoss
3554000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
-17528000 USD
us-gaap Profit Loss
ProfitLoss
-48523000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
122831000 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
133355000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
40500000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
50000000 USD
CY2017Q2 us-gaap Purchase Obligation
PurchaseObligation
107500000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
49341000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
13525000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31348000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59170000 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32593000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58615000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-729954000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-745935000 USD
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
22807000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
42706000 USD
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
28966000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
51197000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
357100000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
648138000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
314213000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
610307000 USD
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
266012000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
518534000 USD
CY2017Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
256671000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
511956000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
117511000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
245513000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
128338000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
265023000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
26105000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
26100000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
15800000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
15844000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2091808000 USD
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2106829000 USD
CY2016Q4 us-gaap Supplies
Supplies
6952000 USD
CY2017Q2 us-gaap Supplies
Supplies
8565000 USD
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
586760 shares
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
549907 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1911000 USD
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1791000 USD
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9481000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10045000 shares
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4816000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4725000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
557040435 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
557040000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
556736000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
556735862 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
564164000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
546691000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559347540 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559348000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
564163808 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
563617000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
563617274 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
547559000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
547558800 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
546691117 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
558892375 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
558892000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</font></div></div>

Files In Submission

Name View Source Status
0000944809-17-000008-index-headers.html Edgar Link pending
0000944809-17-000008-index.html Edgar Link pending
0000944809-17-000008.txt Edgar Link pending
0000944809-17-000008-xbrl.zip Edgar Link pending
copyofopk-3312017xex311.htm Edgar Link pending
copyofopk-3312017xex312.htm Edgar Link pending
copyofopk-3312017xex321.htm Edgar Link pending
copyofopk-3312017xex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
opk-20170630.xml Edgar Link completed
opk-20170630.xsd Edgar Link pending
opk-20170630_cal.xml Edgar Link unprocessable
opk-20170630_def.xml Edgar Link unprocessable
opk-20170630_lab.xml Edgar Link unprocessable
opk-20170630_pre.xml Edgar Link unprocessable
opk-6302017x10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending